Crystalline form of a pyridyl-piperazinyl hepatitis c virus inhibitor
WO2013148768A1
Crystalline forms of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxypropionic acid isopropyl ester
TW201336839A
Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester
EP2760826A1
Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
WO2012166389A1
Neprilysin inhibitors
CA2835220A1
Neprilysin inhibitors
SG190432A1
Neprilysin inhibitors
WO2012075239A1
Serotonin reuptake inhibitors
KR20130130730A
Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
WO2012061552A1
Novel inhibitors of hepatitis c virus
WO2012051103A1
Serotonin reuptake inhibitors
WO2012044825A1
Crystalline oxalate salts of a diamide compound
JP2011219500A
Biphenyl compound useful as muscarinic receptor antagonist
WO2012009166A1
Process for preparing a biphenyl-2-ylcarbamic acid
SG186789A1
Crystalline form of a 3-phenoxymethylpyrrolidine compound
WO2011109579A1
Crystalline alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid and methods for preparing thereof
WO2011085291A1
1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
